All-cause mortality in young women with endometrial cancer receiving progesterone therapy

Volume: 217, Issue: 6
Published: Aug 24, 2017
Abstract
Background null Uterine-preserving therapy with progesterone may be used in young women with endometrial cancer who desire fertility preservation. Such therapy delays definitive treatment with hysterectomy. null null null Objective null We examined the use and safety of progestational therapy in young women with endometrial cancer. The primary outcome of the analysis was overall survival. null null null Study Design null We identified women ≤49...
Paper Details
Title
All-cause mortality in young women with endometrial cancer receiving progesterone therapy
Published Date
Aug 24, 2017
Volume
217
Issue
6
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.